Yahoo Canada Web Search

Search results

  1. Jun 26, 2024 · “It has become increasingly apparent that a new, more powerful class of anti-malarials is needed, especially to combat severe malaria,” said Dr. Jonathan Kurtis, one of Ocean’s Scientific Co-Founders.

  2. Jun 10, 2024 · Jonathan Kurtis, M.D., Ph.D. Title: Professor. Institution: Brown University. Location: Rhode Island. Subspecialties: Blood bank / transfusion medicine, Clinical pathology. Status: Staff. Email: jonathan_kurtis@brown.edu. Consultations: No. Focus Groups: No. Website Doximity ResearchGate. QR code. Home > Directory > Jonathan Kurtis, M.D., Ph.D.

  3. 5 days ago · Ocean Biomedical (NASDAQ: OCEA) Will Host an R&D Update Today on Malaria, and Fibrosis Programs with Scientific Co-founders Jack A. Elias, MD, and Jonathan Kurtis, MD PhD. Presentation will be hosted live on Ocean Biomedical's Youtube Channel at 2:00pm ET

    • 3.91
    • 98.59M
    • 48.16M
    • 34.65M
  4. Jun 19, 2024 · OCEA Ocean Biomedical Inc Ocean Biomedical (NASDAQ: OCEA) Will Host an R&D Update Today on Malaria, and Fibrosis Programs with Scientific Co-founders Jack A. Elias, MD, and Jonathan Kurtis,...

  5. 5 days ago · Statement of acquisition of beneficial ownership by individuals. Company profile for Ocean Biomedical, Inc. (OCEA) with a description, list of executives, contact details and other key facts.

  6. 2 days ago · REUTERS. 5. Dr. Kevin Cannard, a Parkinson’s disease specialist, met with President Biden’s personal physician at the White House in January. The fourth person has not been identified in the ...

  7. Jul 2, 2024 · Ocean Biomedical (NASDAQ: OCEA) Announces $1 Million Falk Award for Malaria Drug Candidate Addressing Evolving Resistance to Artemisinin-Based Therapeutics to Chief Scientist Dr. Jonathan Kurtis. By Marketwired • 10-24-2023

  1. Related searches

    jon kurtis md -